Ignite Creation Date:
2024-05-05 @ 11:40 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01382797
Status:
COMPLETED
Last Update Posted:
2012-06-13
First Post:
2011-06-24
Brief Title:
ALK37-005 A Study of ALKS 37 RDC-1036 in Adults With Opioid-induced Constipation OIC
Sponsor:
Alkermes Inc
Organization:
Alkermes Inc
Study Overview
Official Title:
A Phase 2b Randomized Double-blind Placebo-controlled Repeat-dose Study to Evaluate the Safety Tolerability and Efficacy of ALKS 37 in Subjects With Opioid-induced Constipation
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety tolerability and efficacy of ALKS 37 when administered daily for 4 weeks to adults with Opioid-induced Constipation OIC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None